# Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment

> **NCT07226947** · NA · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Obesity
- Body Composition

## Interventions

- **DEVICE:** Smartwatch activity and body composition monitor
- **BEHAVIORAL:** General guidance on recommended exercise

## Key facts

- **NCT ID:** NCT07226947
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-24
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07226947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07226947, "Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07226947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*